Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
World
Daniel Keane

Northern American researchers sign deal to trial psychedelic medicines in London

Researchers have turned to London to trial therapeutic benefits of psychedelic medicines (Stock image)

(Picture: PA Archive)

North American drug developers have signed a deal with a British company to trial the therapeutic benefits of psychedelic medicines in London.

Canada and US-based drug developers Mindset, PharmAla, Mydecine and Psyence have partnered with Clerkenwell Health, a clinical research firm, to trial their drugs in the capital.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.